Viewing Study NCT07020260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-02 @ 3:46 AM
Study NCT ID: NCT07020260
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-13
First Post: 2025-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
Sponsor: Princess Maxima Center for Pediatric Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAR T-cell Therapy View
None relapsed B-cell malignancies View
None refactory B-cell malignancies View
None B-NHL View
None B-cell ALL View